AzurRx BioPharma (AZRX) News Today → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free AZRX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineYS YS Biopharma Co., Ltd.seekingalpha.com - April 11 at 12:48 PMHanAll Biopharma Opens Applications for the 2023 Pharmaceutical Industry Fellowship Programfinance.yahoo.com - April 19 at 9:11 AMFirst Wave BioPharma Shares Jump 21% on FDA Review of Adrulipase IND Filingmarketwatch.com - January 15 at 11:34 PMFWBI First Wave BioPharma, Inc.seekingalpha.com - September 16 at 8:55 PMFirst Wave BioPharma Inc (FWBI)investing.com - April 30 at 7:57 PMFirst Wave BioPharma Increuters.com - October 1 at 8:38 AMAzurRx BioPharma Changes Name to First Wave BioPharmamarketwatch.com - September 21 at 3:26 PMAzurRx BioPharma to Change Corporate Name to First Wave BioPharma Todayfinance.yahoo.com - September 21 at 3:26 PMAzurRx BioPharma To Acquire First Wave Bio In Transformative $229 Million Deal; Significantly Expands GI and IBD Treatment Pipeline (NASDAQ: AZRX)benzinga.com - September 14 at 5:42 PMWhy AzurRx BioPharma's Stock Is Trading Higher Todaymsn.com - September 14 at 5:42 PMAzurRx (AZRX) Announces First Wave Bio Acquisition for $229Mfinance.yahoo.com - September 14 at 5:42 PMmarketbeat.com - September 14 at 9:36 AMAzurRx BioPharma CEO Issues Letter to Shareholders Regarding Recent Acquisition of First Wave ...apnews.com - September 14 at 8:34 AMAzurRx BioPharma CEO Issues Letter to Shareholders Regarding Recent Acquisition of First Wave Bio and Creation of First Wave BioPharmafinance.yahoo.com - September 14 at 8:34 AMAzurRx BioPharma To Acquire First Wave Bio For $229Mfinance.yahoo.com - September 13 at 5:03 PMAzurRx Announces Acquisition Of First Wave Bio, And Creation Of First Wave BioPharmanasdaq.com - September 13 at 12:03 PMAzurRx BioPharma, Inc.: AzurRx BioPharma Announces Reverse Stock Splitfinanznachrichten.de - September 13 at 6:28 AMAzurRx BioPharma Announces Acquisition of First Wave Bio and its Proprietary Niclosamide Formulations Targeting Multi-Billion Dollar Inflammatory Bowel Disease Indicationsfinance.yahoo.com - September 13 at 6:28 AMAzurRx BioPharma Announces Reverse Stock Splitfinance.yahoo.com - September 10 at 5:50 PMAzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial ...apnews.com - September 10 at 12:50 PMAzurRx Activates New Clinical Trial Sites In India For Gastrointestinal Infections COVID-19 Studynasdaq.com - September 10 at 12:50 PMAzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal Infectionsfinance.yahoo.com - September 10 at 12:50 PMDMC Recommends AzurRx Continues Gastrointestinal Infections COVID-19 Studymarkets.businessinsider.com - September 9 at 9:55 AMAzurRx BioPharma Announces Positive Results from Independent Data Monitoring Committee Review of Safety Data from Part 1 of RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infectionsfinance.yahoo.com - September 9 at 9:55 AMAzurRx BioPharma Submits an Investigational New Drug Application for Niclosamide as Treatment for Grade 1 and Grade 2 Immune Checkpoint Inhibitor-Associated Colitisfinance.yahoo.com - September 8 at 12:54 PMAzurRx BioPharma to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conferenceca.finance.yahoo.com - September 7 at 8:34 PMAzurRx BioPharma to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conferencefinance.yahoo.com - September 7 at 8:34 PMAZURRX BIOPHARMA INC COM USD0.0001(AZRX)fool.com - September 5 at 8:49 PMAzurRx BioPharma Shares Rally on MS1819 Study Results >AZRXmarketwatch.com - August 18 at 5:56 PMWhy AzurRx Stock Is Trading Higher After MS1819 Combo Therapy Data?finance.yahoo.com - August 18 at 5:56 PMAzurRx BioPharma Announces Positive Topline Data For Phase 2 MS1819 Combination Therapy Trial ...apnews.com - August 18 at 7:35 AMAzurRx BioPharma Announces Positive Topline Data For Phase 2 MS1819 Combination Therapy Trial in Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency (EPI)finance.yahoo.com - August 18 at 7:35 AMAzurRx BioPharma Announces WHO Publication of “Adrulipase Alfa” as International Nonproprietary Name for MS1819finance.yahoo.com - August 17 at 8:44 AMAzurRx BioPharma Completes Initial Cohort Enrollment into Part 1 of its RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infectionsfinance.yahoo.com - August 12 at 3:08 PMAzurRx BioPharma Adds New Clinical Trial Sites in Ukraine for Phase 2 RESERVOIR Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infectionsfinance.yahoo.com - August 10 at 7:50 AMAzurRx BioPharma Announces Closing of $5.75 Million Bought Deal Offering and Exercise in Full ...apnews.com - July 28 at 7:20 AMAzurRx BioPharma shares are trading lower after the company announced it increased its previously announced bought deal offering to $5 million.benzinga.com - July 24 at 6:03 PMAzurRx BioPharma, Inc. Common Stock (AZRX)nasdaq.com - July 23 at 8:05 PMAzurRx BioPharma Increases Previously Announced Bought Deal to $5.0 Millionfinance.yahoo.com - July 22 at 11:20 PMAzurRx BioPharma Announces $3.0 Million Bought Deal Offering of Common Stockfinance.yahoo.com - July 22 at 6:20 PM Get AzurRx BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AZRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. AZRX Media Mentions By Week AZRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZRX News Sentiment▼0.000.32▲Average Medical News Sentiment AZRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZRX Articles This Week▼00▲AZRX Articles Average Week Get AzurRx BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AZRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CASI News APRE News THTX News LEXX News SPRB News JAN News VIRX News APM News FBIO News IPA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AZRX) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AzurRx BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
